Jump to content

Christopher Zarins

From Wikipedia, the free encyclopedia
Christopher Zarins
Kristaps (Kristofers) Zariņš
Born (1943-12-02) December 2, 1943 (age 80)
CitizenshipUnited States, Latvia
Alma materBA, Lehigh University (1964)
MD, Johns Hopkins University School of Medicine (1968)
Occupation(s)Surgeon, researcher, professor, entrepreneur
Years active1969-present
Known forHeartFlow
Children3

Christopher K. Zarins (born on 2 December 1943 in Tukums, Latvia) is an American-Latvian surgeon and professor emeritus who specializes in vascular biology and pathology.[1]

Family background and education

[edit]

Zarins was born during the Second World War in 1943 in the family of Tukums Lutheran pastor Rihards Zariņš (1913–2006) and English teacher Maria Zarinš. In October 1944 he fled to Sweden with his parents and in November 1946 he moved to the United States.[2][3]

In 1960, he graduated from the Brooklyn Technical High School in New York, in 1964 he graduated from Lehigh University with B.A. in biology. In 1968, he received his Doctor of Medicine (M.D.) degree from Johns Hopkins University in Baltimore.

From 1968 to 1973 he worked at the Johns Hopkins Hospital, from 1974 to 1979 at the US Navy Medical Center in San Diego. From 1976 to 1993 he taught at the University of Chicago, was a vascular surgeon at the Medical Center, in 1982 he became a professor. In 1993, he moved to California where he began working as a vascular surgeon at Stanford University Medical Center.

Scientific work

[edit]

Zarins is an author or co-author of more than 15 books and more than 350 scientific articles in the fields of vascular biomechanics and pathobiology of atherosclerosis, carotid stenosis, aortic aneurysms and endovascular therapy.[4][5]

HeartFlow

[edit]

In 2007, Zarins together with biomedical engineer Charles Anthony Taylor founded HeartFlow, Inc., a medical technology company based in Redwood City, California, that developed non-invasive, real-time virtual modeling tool for coronary artery disease (CAD) intervention using estimation of fractional flow reserve (FFR).[6][7][8][9]

References

[edit]
  1. ^ "The Zarins Lab - Stanford University School of Medicine". 2008-07-24. Archived from the original on 2008-07-24. Retrieved 2022-11-02.
  2. ^ "Patron of the Month. Donations from Zariņš family have contributed to development of UL history studies". www.lu.lv. 22 January 2019. Retrieved 2022-11-02.
  3. ^ "Antra, Bertrams and Kristaps Zariņš". www.fonds.lv. Retrieved 2022-11-02.
  4. ^ "CAP Profile". Stanford University. Retrieved 2022-11-02.
  5. ^ "Christopher K. Zarins' Profile | Stanford Profiles". Stanford University.
  6. ^ Johnston, Birgit (2021-01-28). "Fogarty Innovation's First Company, HeartFlow, Continues to Break Ground". Fogarty Innovation. Retrieved 2022-11-02.
  7. ^ "How this founder went from academia to a $1.5 billion valuation". San Francisco Business Times. Aug 9, 2018. Retrieved 2022-11-02.
  8. ^ "Christopher K. Zarins, M.D. COF-1901 - AIMBE". The American Institute for Medical and Biological Engineering (AIMBE). Retrieved 2022-11-02.
  9. ^ "Charles Anthony Taylor". Eindhoven University of Technology research portal. Retrieved 2022-11-03.
[edit]